Hemostasis Today

May, 2026
May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Mostafa Meshref: Find Our Research Contributions at ESOC 2026
May 10, 2026, 11:57

Mostafa Meshref: Find Our Research Contributions at ESOC 2026

Mostafa Meshref, Assistant Lecturer of Neurology in the Faculty of Medicine at Al-Azhar University, shared on LinkedIn:

”The European Stroke Organisation Congress 2026 (ESOC 2026) has concluded.

Despite being unable to attend in person, I had the wonderful honor to see our five accepted abstracts published online in the European Stroke Journal.

Three of those abstracts were accepted as e-poster presentations.

Additionally, these abstracts were previously published as full manuscripts.

You can read them as follows:

  • Abstract number: ESOC2026A286 Clinical efficacy of combination therapy vs. Endovascular treatment alone in acute ischemic stroke: A retrospective study.
  • Abstract number: ESOC2026A316 Postpartum vertebral artery dissection: clinical features, course, and outcomes in a pooled analysis of case reports.
  • Abstract number: ESOC2026A245 Clinical outcomes following mechanical thrombectomy in hyperacute posterior circulation stroke.

Thanks to all team members and my colleagues and professors at my university.”

Title 1: Outcomes of endovascular treatment alone or with intravenous alteplase in acute ischemic stroke Patients: A retrospective cohort study

Authors: Mahmoud Galal Ahmed, Nour Shaheen, Ahmed Shaheen, Mostafa Meshref, Abdulqadir J. Nashwan, Nourelhuda Ahmed Nassar, Khaled Sobh

Mostafa Meshref: Find Our Research Contributions at ESOC 2026

Title 2: Clinical Characteristics, Course, and Outcomes of Vertebral Artery Dissections in the Postpartum Period; a Pooled Analysis of Published Case Reports

Authors:Rehab Adel Diab, Nour Shaheen, Abdel-rahman Mohamed, Mahmoud Tarek Hefnawy, Dilawer Chofan Charo, Mostafa Meshref

Mostafa Meshref: Find Our Research Contributions at ESOC 2026

Stay updated on all scientific advances with Hemostasis Today.